Designing optimized drug candidates with Generative Adversarial Network

Drug design is an important area of study for pharmaceutical businesses. However, low efficacy, off-target delivery, time consumption, and high cost are challenges and can create barriers that impact this process. Deep Learning models are emerging as a promising solution to perform de novo drug desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi, Maryam, Santos, Beatriz P., Pereira, Tiago C., Sofia, Raul, Monteiro, Nelson R. C., Simões, Carlos J. V., Brito, Rui, Ribeiro, Bernardete, Oliveira, José L., Arrais, Joel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233801/
https://www.ncbi.nlm.nih.gov/pubmed/35754029
http://dx.doi.org/10.1186/s13321-022-00623-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233801/
https://www.ncbi.nlm.nih.gov/pubmed/35754029
http://dx.doi.org/10.1186/s13321-022-00623-6

Ejemplares similares